Go to deals
Healthcare

Sanofi has acquired Zentiva Slovakia

The public shareholders of Zentiva Slovakia have sold approximately a 3% stake in the company to Sanofi, in a share buyback transaction. Financial details have not been disclosed.

Sanofi is a global and diversified healthcare leader which researches, develops and distributes therapeutic solutions focused on patients’ needs. The company has core strengths in healthcare, with six growth platforms: emerging markets, vaccines, consumer healthcare, diabetes treatments, innovative products and animal health.

Zentiva Slovakia is a producer of pharmaceutical products. Its product range consists of approximately 270 references in 500 pharmaceutical presentations, of which 180 are bound by prescription and 100 are OTC preparations or food supplements. The company focuses on the treatment of cardiovascular disorders, inflammatory conditions, pain, infections and diseases of the central nervous system and the gastrointestinal and urinary tracts. It also offers over-the-counter medicines and dietary supplements. It offers a range of therapeutic areas. In addition to generic drugs, Zentiva Slovakia also produces cosmetics and pharmaceutical substances.

Oaklins' team in Slovakia acted as financial advisor to the buyer in this transaction.

Parties

Talk to the deal team

Ondřej Berka

Managing Director
Prague, Czech Republic
Oaklins WOOD & Co.

Related deals

CARSO Group has acquired a majority stake in AQCF Group
Private Equity | Business Support Services | Healthcare

CARSO Group has acquired a majority stake in AQCF Group

CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.

Learn more
Prestige Inhome Care has found a long-term strategic partner
Healthcare

Prestige Inhome Care has found a long-term strategic partner

Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.

Learn more
Cara Care has been acquired by Mahana Therapeutics
Private Equity | Healthcare | TMT

Cara Care has been acquired by Mahana Therapeutics

Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.

Learn more